We are a week away from our 4th Annual Living with EGFR-Mutant Lung Cancer Forum! There's still time to register! Click here to register: bit.ly/4aG2rQc

Today is the Day! Please join us for our Fourth Annual Living with EGFR-Mutant Lung Cancer Forum. Link to register - bit.ly/4aG2rQc

If you didn't have the opportunity to sit in on our Fourth Annual Living with EGFR-Mutant Lung Cancer Virtual Forum. Please check out our recordings on YouTube! youtube.com/playlist?list=…

It's Lung Cancer Awareness month; here's some information from Dr. Jänne. linkedin.com/posts/american…

November is #LungCancerAwarenessMonth. At the Chen-Huang Center for EGFR-Mutant Lung Cancer, we see over 300 EGFR patients per year! If you would like to become a patient, please email us - [email protected] #LungCancer #EGFR #CancerCare #LungCancerAwareness

We’re thrilled to be attending the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, where more than 115 studies led by Dana-Farber affiliated researchers will be presented. View oral and poster presentations and the press program here: bit.ly/3H2MZ7c

Follow us at the DFCI EGFR Center for updates on emerging data from #ASCO25 Dana Farber's EGFR-Mutant Lung Cancer Center #NSCLC #EGFR OptiTROP-Lung03: sac-TMT NeoADAURA: neoadj osi/chemo HERTHENA-Lung02: HER3-DXd vs doublet Temab-A MET ADC SACHI: osi/savolitinib MET+ Zipalertinib and BAY2927088 EGFR ex20ins+

“Even one comorbid medical condition decrease probability of clinic trial participation.”- Dr. Julia Rotow MD @asco #ASCO25 EGFR Resisters Dana Farber's EGFR Mutant Lung Cancer Center #LCSM

Dr. Pasi Janne at #ASCO25 with update on KRYSTAL7: phase II study of first line adagrasib plus pembrolizumab for #KRAS G12C NSCLC. RR 44% (61% for PDL1 high). mDOR 26.3m, PFS 11m (27.7m for PDL1 high), OS 18.3m. 17% had to stop pembro for TRAE.

 🎙️NEW PODCAST EPISODE! All In The Family - This vital conversation tackles the complex question of inheritance & environment in understanding lung cancer development. Listen on all podcast platforms or online: upstagelungcancer.org/podcasts/all-i… #Lilly #Bayer #Takeda #BlueprintMedicines

FDA grants accelerated approval to a treatment for non-small cell lung cancer. fda.gov/drugs/resource…

We are excited to have this new treatment option available for our patients with EGFR mutated non-small cell lung cancer!

Check out this clip featuring Center Faculty Drs. Pasi Jänne and Julia Rotow MD in conversation about updates from ASCO 2025 related to #EGFR-mutant #lungcancer! #lcsm #NSCLC Watch the full conversation here: youtu.be/eUqCJCZ313c

#FDA grants accelerated approval to a treatment for non-small cell lung cancer. fda.gov/drugs/resource…

🚨 DID YOU KNOW? Lung cancer is the leading cause of cancer deaths globally and it disproportionately affects non-tobacco users from East Asian and Latinx communities who are often ineligible for routine screening. The EQUAL Study is here to change that!! #EQUALStudy

A true masterclass on 1st-line treatment for EGFR+ NSCLC by Julia Rotow MD kicking off the second session at OncLive.com #BTGLung2025 👏 Looking forward to more great talks from Xiuning Le MD PhD, Ana I. Velázquez Mañana, MD, MSc, FASCO, Joshua Sabari, MD, and Elaine Shum. #LungCancer #Oncology #LCSM

Young Lung Cancer Initiative EGFR Resisters Narjust Florez, MD, FASCO Lung Cancer Research Foundation American Lung Association Leah Phillips, diagnosed at 43, was told she had 6–12 months to live. A never-smoker with 3 kids, she now wears 5 black ribbon tattoos, one for each year she’s survived. nytimes.com/2025/07/22/wel… #LungCancerAwareness #NeverSmoker

Today is #WorldLungCancerDay! Share these facts on social media and have your friends and family share, too! Make sure everyone you know realizes that anyone with lungs can get lung cancer. Visit lungevity.org to learn more about lung cancer. #AnyoneWithLungs

We were thrilled to host Dr. William Pao for our endowed lecture! He spoke with Drs. Pasi Jänne & Jia Luo about his book “Breakthrough,” highlighting successful drug development efforts for conditions including #EGFR mutant #lungcancer. Thanks to Dr. Pao for sharing his insights!